<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://pasen.chat/wiki/index.php?action=history&amp;feed=atom&amp;title=Vigabatrin_Side_Effects.</id>
	<title>Vigabatrin Side Effects. - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://pasen.chat/wiki/index.php?action=history&amp;feed=atom&amp;title=Vigabatrin_Side_Effects."/>
	<link rel="alternate" type="text/html" href="http://pasen.chat/wiki/index.php?title=Vigabatrin_Side_Effects.&amp;action=history"/>
	<updated>2026-05-02T22:28:17Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.39.1</generator>
	<entry>
		<id>http://pasen.chat/wiki/index.php?title=Vigabatrin_Side_Effects.&amp;diff=53729&amp;oldid=prev</id>
		<title>RickyM9183 at 06:42, 20 July 2024</title>
		<link rel="alternate" type="text/html" href="http://pasen.chat/wiki/index.php?title=Vigabatrin_Side_Effects.&amp;diff=53729&amp;oldid=prev"/>
		<updated>2024-07-20T06:42:05Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 06:42, 20 July 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;−&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Before beginning SABRIL, inform&lt;/del&gt; your doctor &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;concerning&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;all&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of your&lt;/del&gt; (or your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;child's&lt;/del&gt;) &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;clinical&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;conditions&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;including&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;clinical&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;depression&lt;/del&gt;, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;mood&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;issues&lt;/del&gt;, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;suicidal&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;thoughts&lt;/del&gt; [https://www.protopage.com/&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;branyau213&lt;/del&gt; Bookmarks] or &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;habits,&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;any&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;type&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;allergic&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;reaction&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;SABRIL,&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;vision&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;problems,&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kidney&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;issues,&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;reduced&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;red&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;cell&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;counts&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(anemia),&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;and&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;any&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kind&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;mental&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;or&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;nervous&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;disease&lt;/del&gt;.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;The&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Vigabatrin&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;REMS&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Program&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;is&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;called&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;for&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;by&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;the&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;FDA&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;make&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;sure&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;notified&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;risk-benefit&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;choices&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;before&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;launching&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;treatment,&lt;/del&gt; and &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;make&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;sure&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;appropriate&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;use&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;vigabatrin&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;while&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;clients&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;are&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;treated.&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;When&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;vision&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;loss&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;will&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;take&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;place,&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;it&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;is&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;not&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;possible&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;for&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;your&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;healthcare&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;company&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;understand&lt;/del&gt;. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;One of the&lt;/del&gt; most &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;common&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;adverse&lt;/del&gt; effects of SABRIL in &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kids&lt;/del&gt; 3 to 16 years is weight gain. With severe vision loss, you might &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;only&lt;/del&gt; have the ability to see things right before you (&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;in some cases&lt;/del&gt; called &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;one-track&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;mind&lt;/del&gt;&quot;). You are at &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;threat&lt;/del&gt; for vision loss with any type of &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;quantity&lt;/del&gt; of SABRIL.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;If you are pregnant or plan to &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;obtain&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;pregnant&lt;/del&gt;, tell your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;health&lt;/del&gt; care &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;provider&lt;/del&gt;. If vision &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;screening&lt;/del&gt; can not be done, your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;doctor&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;might&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;continue&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;suggesting&lt;/del&gt; SABRIL, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;but&lt;/del&gt; will not &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;have&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;the ability&lt;/del&gt; to &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;look for&lt;/del&gt; any kind of vision loss. &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;If&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;vision&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tests&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;are&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;refrained&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;from doing frequently, your doctor may stop prescribing&lt;/del&gt; SABRIL for you (or your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;child&lt;/del&gt;).&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;+&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Inform&lt;/ins&gt; your doctor &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;immediately&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;if&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;you&lt;/ins&gt; (or your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;youngster&lt;/ins&gt;)&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;:&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;may&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;not&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;be&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;seeing as well as before beginning SABRIL; begin to&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;journey&lt;/ins&gt;, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;run&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;into points&lt;/ins&gt;, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;or&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;are much more clumsy than common&lt;/ins&gt; [https://www.protopage.com/&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;dairicvpz7&lt;/ins&gt; Bookmarks]&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;; are shocked by individuals&lt;/ins&gt; or &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;points&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;being&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;available&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;in&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;front&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;you&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;that&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;appear&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;ahead&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;out&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;nowhere;&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;or&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;if&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;your&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;infant&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;is&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;acting&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;in&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;a&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;different&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;way&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;than&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;normal&lt;/ins&gt;.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;SABRIL&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(vigabatrin)&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;is&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;a&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;prescription&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;medicine&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;made&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;use&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;with&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;various&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;other&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;therapies&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;in&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;children&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;and&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;adults&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;years of age&lt;/ins&gt; and &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;older&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;with&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;refractory&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;complex&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;partial&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;seizures&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(CPS)&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;who&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;have&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;not&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;responded&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;all&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;right&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;a&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;number&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;other&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;therapies&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;and&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;if&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;the&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;feasible&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;benefits&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;exceed&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;the&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;threat of vision loss&lt;/ins&gt;. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;The&lt;/ins&gt; most &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;typical&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;negative&lt;/ins&gt; effects of SABRIL in &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;youngsters&lt;/ins&gt; 3 to 16 years is weight gain. With severe vision loss, you might &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;just&lt;/ins&gt; have the ability to see things right before you (&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;often&lt;/ins&gt; called &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tunnel&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;vision&lt;/ins&gt;&quot;). You are at &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;risk&lt;/ins&gt; for vision loss with any type of &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;amount&lt;/ins&gt; of SABRIL.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;If you are pregnant or plan to &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;get&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;expectant&lt;/ins&gt;, tell your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;medical&lt;/ins&gt; care &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;carrier&lt;/ins&gt;. If vision &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;testing&lt;/ins&gt; can not be done, your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;healthcare&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;provider&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;may&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;proceed prescribing&lt;/ins&gt; SABRIL, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;however&lt;/ins&gt; will not &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;be&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;able&lt;/ins&gt; to &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;expect&lt;/ins&gt; any kind of vision loss. &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Your&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;healthcare&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;carrier&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;might&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;quit&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;recommending&lt;/ins&gt; SABRIL for you (or your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kid&lt;/ins&gt;)&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;if vision tests are not done routinely&lt;/ins&gt;.&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>RickyM9183</name></author>
	</entry>
	<entry>
		<id>http://pasen.chat/wiki/index.php?title=Vigabatrin_Side_Effects.&amp;diff=53710&amp;oldid=prev</id>
		<title>LeifNiven53838: Created page with &quot;Before beginning SABRIL, inform your doctor concerning all of your (or your child's) clinical conditions including clinical depression, mood issues, suicidal thoughts [https://www.protopage.com/branyau213 Bookmarks] or habits, any type of allergic reaction to SABRIL, vision problems, kidney issues, reduced red cell counts (anemia), and any kind of mental or nervous disease.&lt;br&gt;&lt;br&gt;The Vigabatrin REMS Program is called for by the FDA to make sure notified risk-benefit cho...&quot;</title>
		<link rel="alternate" type="text/html" href="http://pasen.chat/wiki/index.php?title=Vigabatrin_Side_Effects.&amp;diff=53710&amp;oldid=prev"/>
		<updated>2024-07-20T06:21:30Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;Before beginning SABRIL, inform your doctor concerning all of your (or your child&amp;#039;s) clinical conditions including clinical depression, mood issues, suicidal thoughts [https://www.protopage.com/branyau213 Bookmarks] or habits, any type of allergic reaction to SABRIL, vision problems, kidney issues, reduced red cell counts (anemia), and any kind of mental or nervous disease.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The Vigabatrin REMS Program is called for by the FDA to make sure notified risk-benefit cho...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Before beginning SABRIL, inform your doctor concerning all of your (or your child's) clinical conditions including clinical depression, mood issues, suicidal thoughts [https://www.protopage.com/branyau213 Bookmarks] or habits, any type of allergic reaction to SABRIL, vision problems, kidney issues, reduced red cell counts (anemia), and any kind of mental or nervous disease.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The Vigabatrin REMS Program is called for by the FDA to make sure notified risk-benefit choices before launching treatment, and to make sure appropriate use of vigabatrin while clients are treated. When vision loss will take place, it is not possible for your healthcare company to understand. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;One of the most common adverse effects of SABRIL in kids 3 to 16 years is weight gain. With severe vision loss, you might only have the ability to see things right before you (in some cases called one-track mind&amp;quot;). You are at threat for vision loss with any type of quantity of SABRIL.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;If you are pregnant or plan to obtain pregnant, tell your health care provider. If vision screening can not be done, your doctor might continue suggesting SABRIL, but will not have the ability to look for any kind of vision loss. If vision tests are refrained from doing frequently, your doctor may stop prescribing SABRIL for you (or your child).&lt;/div&gt;</summary>
		<author><name>LeifNiven53838</name></author>
	</entry>
</feed>